Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Return on Capital Employed: 2016-2024

Historic Return on Capital Employed for Sunshine Biopharma (SBFM) over the last 9 years, with Dec 2024 value amounting to -0.26%.

  • Sunshine Biopharma's Return on Capital Employed fell 6.00% to -0.26% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.26%, marking a year-over-year decrease of 6.00%. This contributed to the annual value of -0.26% for FY2024, which is 5.00% down from last year.
  • Sunshine Biopharma's Return on Capital Employed amounted to -0.26% in FY2024, which was down 22.02% from -0.21% recorded in FY2023.
  • Sunshine Biopharma's Return on Capital Employed's 5-year high stood at 1.20% during FY2020, with a 5-year trough of -3.07% in FY2022.
  • Over the past 3 years, Sunshine Biopharma's median Return on Capital Employed value was -0.26% (recorded in 2024), while the average stood at -1.18%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first crashed by 279bps in 2021, then surged by 286bps in 2023.
  • Yearly analysis of 5 years shows Sunshine Biopharma's Return on Capital Employed stood at 1.20% in 2020, then tumbled by 279bps to -1.59% in 2021, then crashed by 148bps to -3.07% in 2022, then surged by 286bps to -0.21% in 2023, then fell by 5bps to -0.26% in 2024.